1,820
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Testosterone, sex hormone-binding globulin and dehydroepiandrosterone levels and cervical length of Egyptian women with a history of recurrent miscarriages, polycystic ovary syndrome and without the conditions at three stages of pregnancy

, , &
Article: 2163625 | Received 30 Apr 2022, Accepted 17 Dec 2022, Published online: 23 Jan 2023

Figures & data

Table 1. Anthropometric data (mean ± sd) of women with a history of recurrent miscarriages (RM, n = 40), polycystic ovary syndrome (PCOS, n = 38) and healthy control group (HC, n = 40) at week eight of pregnancy.

Table 2. Mean (±sd) cervical length (CL, mm) and total testosterone (TT, mmol/L), sex hormone-binding globulin (SHBG, mmol/L) dehydroepiandrosterone (DHEA, mmol/L), free androgen index (FAI) levels of women with a history of recurrent miscarriages (RM, n = 40), polycystic ovary syndrome (PCOS, n = 38) and healthy controls (HC, n = 40) at three stages of pregnancy.

Table 3. Mean (±sd) changes of cervical length (CL, mm) and total testosterone (TT, mmol/L), sex hormone-binding globulin (SHBG, mmol/L) dehydroepiandrosterone (DHEA, mmol/L), free androgen index (FAI) levels of women with a history of recurrent miscarriages (RM, n = 40), polycystic ovary syndrome (PCOS, n = 38) and healthy controls (HC, n = 40) with the progress of pregnancy.

Figure 1. Changes in mean (±se) dehydroepiandrostrone (DHEA) concentration of women with recurrent miscarriages, polycystic ovary syndrome, and healthy control group between pergnancy week 8 and 20.

Notationsap = 0.000(8 vs. 16 week); bp = 0.000 (8 vs. 20 week);cp = 0.000 (16 vs. 20 week).

Figure 1. Changes in mean (±se) dehydroepiandrostrone (DHEA) concentration of women with recurrent miscarriages, polycystic ovary syndrome, and healthy control group between pergnancy week 8 and 20.Notations – ap = 0.000(8 vs. 16 week); bp = 0.000 (8 vs. 20 week);cp = 0.000 (16 vs. 20 week).

Figure 2. Changes in mean (±se) sex hormone binding globulin (SHBG) concentration of women with recurrent miscarriages, polycystic ovary syndrome, and healthy control group between pergnancy week 8 and 20.

Notationsap = 0.000(8 vs. 16 week); bp = 0.000 (8 vs. 20 week); cp < 0.05, dp < 0.001, ep < 0.000, (16 vs. 20 week).

Figure 2. Changes in mean (±se) sex hormone binding globulin (SHBG) concentration of women with recurrent miscarriages, polycystic ovary syndrome, and healthy control group between pergnancy week 8 and 20.Notations – ap = 0.000(8 vs. 16 week); bp = 0.000 (8 vs. 20 week); cp < 0.05, dp < 0.001, ep < 0.000, (16 vs. 20 week).

Figure 3. Changes in mean (±se) cervical length of women with recurrent miscarriages, polycystic ovary syndrome, and healthy control group between pergnancy week 8 and 20.

Notationsap < 0.05, bp < 0.001 (8 vs. 16 week); cp = 0.001, cp = 0.000 (8 vs. 20 week); d p < 0.05 ep = 0.001 (16 vs. 20 week).

Figure 3. Changes in mean (±se) cervical length of women with recurrent miscarriages, polycystic ovary syndrome, and healthy control group between pergnancy week 8 and 20.Notations – ap < 0.05, bp < 0.001 (8 vs. 16 week); cp = 0.001, cp = 0.000 (8 vs. 20 week); d p < 0.05 ep = 0.001 (16 vs. 20 week).
Supplemental material

Supplemental Material

Download Zip (165.3 KB)